⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21382091 | 0.75 | — | — | |
| SCHEMBL1127327 | 0.74 | — | — | |
| SCHEMBL5126603 | 0.74 | — | — | |
| SCHEMBL28409402 | 0.74 | CA1 (0.44) | — | |
| SCHEMBL2858061 | 0.71 | — | — | |
| SCHEMBL337228 | 0.71 | — | — | |
| SCHEMBL2442152 | 0.69 | — | — | |
| SCHEMBL187410 | 0.69 | CA1 (0.55) | — | |
| SCHEMBL10457653 | 0.69 | DPP4 (0.53) | — | |
| SCHEMBL19880292 | 0.69 | FAAH (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10882861-B2 | Purine nucleotide derivatives | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2021-01-05 | — | — | US | claimed |
| US-20190300532-A1 | PURINE NUCLEOTIDE DERIVATIVES | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2019-10-03 | — | — | US | claimed |
| WO-2017201382-A1 | PURINE NUCLEOTIDE DERIVATIVES | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2017-11-23 | — | — | WO | claimed |
| US-4826852-A | Novel ergolinyl compounds nitrogen-substituted in the 8-position, useful for treating dopamine deficiency | SCHERING AKTIENGESELLSCHAFT (DE) | 1989-05-02 | — | — | US | claimed |
| EP-0082808-B1 | NOVEL ERGOLINYL COMPOUNDS NITROGEN-SUBSTITUTED IN THE 8-POSITION, THEIR PREPARATION, AND USE AS MEDICINAL AGENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1987-05-27 | — | — | EP | claimed |
| EP-0082808-A1 | Novel ergolinyl compounds nitrogen-substituted in the 8-position, their preparation, and use as medicinal agents | SCHERING AKTIENGESELLSCHAFT (DE) | 1983-06-29 | — | — | EP | claimed |
| EP-4740010-A1 | NEGATIVE TUNE STANDARD FOR MASS SPECTROMETRY | Agilent Technologies, Inc. (US) | 2026-05-13 | — | — | EP | disclosed |
| US-20260109989-A1 | COMPOSITIONS AND METHODS FOR THE SYNTHESIS AND IDENTIFICATION OF COVALENT APTAMERS | UNIV HAWAII (US) | 2026-04-23 | — | — | US | disclosed |
| US-12371694-B2 | Compositions and methods for the synthesis and identification of covalent aptamers | UNIVERSITY OF HAWAII (US) | 2025-07-29 | — | — | US | disclosed |
| WO-2025010077-A1 | NEGATIVE TUNE STANDARD FOR MASS SPECTROMETRY | AGILENT TECHNOLOGIES, INC. (US) | 2025-01-09 | — | — | WO | disclosed |
| EP-4441066-A1 | SYNTHESIS OF 2' ACETYL-ESTER PROTECTED NUCLEOSIDES | Hongene Biotech Corporation (US) | 2024-10-09 | — | — | EP | disclosed |
| CN-118317970-A | Synthesis of 2' acetyl-ester protected nucleosides | 兆维生物科技公司 | 2024-07-09 | — | — | CN | disclosed |
| US-11897914-B2 | Synthesis of 2′ protected nucleosides | HONGENE BIOTECH CORPORATION (US) | 2024-02-13 | — | — | US | disclosed |
| US-20160002282-A1 | Protected Monomer and Method of Final Deprotection for RNA Synthesis | AGILENT TECHNOLOGIES, INC. | 2016-01-07 | — | — | US | disclosed |
| US-20120289691-A1 | PROTECTED MONOMER AND METHOD OF FINAL DEPROTECTION FOR RNA SYNTHESIS | AGILENT TECHNOLOGIES, INC. (US) | 2012-11-15 | — | — | US | disclosed |
| US-20120184724-A1 | PROTECTED MONOMERS AND METHODS OF DEPROTECTION FOR RNA SYNTHESIS | AGILENT TECHNOLOGIES, INC. (US) | 2012-07-19 | — | — | US | disclosed |
| EP-2331558-A2 | PROTECTED MONOMERS AND METHODS OF DEPROTECTION FOR RNA SYNTHESIS | Agilent Technologies, Inc. (US) | 2011-06-15 | — | — | EP | disclosed |
| US-20100076183-A1 | PROTECTED MONOMER AND METHOD OF FINAL DEPROTECTION FOR RNA SYNTHESIS | AGILENT TECHNOLOGIES, INC. | 2010-03-25 | — | — | US | disclosed |
| US-4826852-A | Novel ergolinyl compounds nitrogen-substituted in the 8-position, useful for treating dopamine deficiency | SCHERING AKTIENGESELLSCHAFT (DE) | 1989-05-02 | — | — | US | disclosed |
| EP-0082808-B1 | NOVEL ERGOLINYL COMPOUNDS NITROGEN-SUBSTITUTED IN THE 8-POSITION, THEIR PREPARATION, AND USE AS MEDICINAL AGENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1987-05-27 | — | — | EP | disclosed |